---
name: Atheln, Inc.
slug: athelnbiomed
site: cro
website_domain: athelnbiomed.com
summary: Atheln provides integrated consulting and strategic development services across product development, CMC, nonclinical, clinical, regulatory affairs, and commercialization for pharma, biotech, and medtech clients.
tagline: Integrated pharma and biotech product development and commercialization consulting.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-09-22T07:03:25.961Z
services_count: 8
modalities_count: 5
indications_count: 1
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Atheln, Inc.

Integrated pharma and biotech product development and commercialization consulting.

Listed on cro.directory.

## Summary

Atheln provides integrated consulting and strategic development services across product development, CMC, nonclinical, clinical, regulatory affairs, and commercialization for pharma, biotech, and medtech clients.

## Services

- Analytical Method Development & Validation
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- Clinical Operations
- Medical Writing
- Translational Research

## Modalities

- Small Molecule
- Biologics (Other)
- Oligonucleotide
- Radiopharmaceutical
- Peptide

## Indications

- Ophthalmology

## Long description

Atheln is a consulting and strategic development firm serving biopharma, biotech, and medtech companies. The firm offers customized, phase-appropriate solutions across the full product lifecycle, including product development strategy and planning, chemistry, manufacturing and controls (CMC), nonclinical development, clinical operations, regulatory affairs, quality assurance and compliance, project management, market research and analysis, commercial strategy, reimbursement and market access, and business development.

The team comprises over 100 industry-seasoned experts with 20–40 years of global strategic and operational experience. Atheln functions as an integrated extension of client development, commercial, or management teams, addressing competency gaps or serving as a full outsourced development partner. The firm's expertise spans small molecules, biologics (including protein therapeutics), oligonucleotides, radiopharmaceuticals, drug-device combination products, and ophthalmic formulations. Key technical competencies include analytical development, formulation development, process development, CMO oversight, regulatory submissions (IND, BLA, NDA, CTA, IMPD), and cGMP compliance.

## Related companies

- [ResolveMass Laboratories Inc.](/companies/resolvemass) (Analytical Method Development & Validation, Regulatory Affairs) — [Compare](/compare/athelnbiomed/resolvemass)
- [CovarsaDx](/companies/covarsadx) (Regulatory Affairs, US FDA Regulatory Strategy) — [Compare](/compare/athelnbiomed/covarsadx)
- [MMS Holdings](/companies/mmsholdings) (Regulatory Affairs, US FDA Regulatory Strategy) — [Compare](/compare/athelnbiomed/mmsholdings)
- [Broughton Group](/companies/broughton-group) (Analytical Method Development & Validation, Regulatory Affairs) — [Compare](/compare/athelnbiomed/broughton-group)
- [Critical Path Institute](/companies/critical-path-institute) (Regulatory Affairs, US FDA Regulatory Strategy) — [Compare](/compare/athelnbiomed/critical-path-institute)
- [Tigermed](/companies/tigermedgrp) (Regulatory Affairs, US FDA Regulatory Strategy) — [Compare](/compare/athelnbiomed/tigermedgrp)
- [Premier Research](/companies/premier-research) (Regulatory Affairs, US FDA Regulatory Strategy) — [Compare](/compare/athelnbiomed/premier-research)
- [Accelsiors](/companies/accelsiors) (Regulatory Affairs, US FDA Regulatory Strategy) — [Compare](/compare/accelsiors/athelnbiomed)

_Profile last updated: 2026-09-22T07:03:25.961Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.